Garry A Nicholson's Net Worth
$370 Thousand
Who is Garry A Nicholson?
Garry A Nicholson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., G1 Therapeutics, Inc., TESARO, Inc., NextCure, Inc., Day One Biopharmaceuticals, Inc., FIVE PRIME THERAPEUTICS, INC., and TScan Therapeutics, Inc..
SEC CIK
Garry A Nicholson's CIK is 0001640861
Past Insider Trading and Trends
2020 was Garry A Nicholson's most active year for acquiring shares with 6 total transactions. Garry A Nicholson's most active month to acquire stocks was the month of May. 2019 was Garry A Nicholson's most active year for disposing of shares, totalling 6 transactions. Garry A Nicholson's most active month to dispose stocks was the month of December. 2019 saw Garry A Nicholson paying a total of $0.00 for 135,000 shares, this is the most they've acquired in one year. In 2019 Garry A Nicholson cashed out on 61,932 shares for a total of $125,325.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Turning Point Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
G1 Therapeutics, Inc. (GTHX) Snapshot price: $7.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -34.39K |
—
|
—
|
0
|
Sep 18
| |||
Form 4
| +41.00% | 10K |
—
|
—
| 34.39K |
Jun 13
| |||
Form 4
| +69.50% | 10K |
—
|
—
| 24.39K |
Jun 15
| |||
Form 4
| +227.84% | 10K |
—
|
—
| 14.39K |
Jun 23
| |||
Form 4
|
∞
| 4.39K |
—
|
—
| 4.39K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
TESARO, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.67K |
$75.00 | -$125,325.00 |
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +31.68% | 402 |
—
|
—
| 1.67K |
Jun 1
| |||
Form 4
|
∞
| 1.27K |
—
|
—
| 1.27K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NextCure, Inc. (NXTC) Snapshot price: $1.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |